Midodrine
Hyponatremia
Hospital Clinic of BarcelonaSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Hyponatremia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tolvaptan King's College Hospital NHS Trust | Phase 4 | BBB |
Empagliflozin University Hospital, Basel, Switzerland | Phase 4 | BB |
SATAVAPTAN MONOPHOSPHATE Sanofi | Phase 3 | BB |
NORMAL HUMAN SERUM ALBUMIN Hospital Clinic of Barcelona | Phase 4 | BB |
Satavaptan Sanofi | Phase 3 | B |
Urea Helbert Rondon Berrios, MD, MS | Phase 2 | CCC |
Ddavp University Hospital, Basel, Switzerland | N/A | D |
Sodium Chloride Department of Medical Services Ministry of Public Health of Thailand | N/A | D |
Same molecule, other indications
Midodrine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →